Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damla Uludağ

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Anticancer Research|July 7, 2021
IL13 Fused <i>Pseudomonas</i> Exotoxin Targets Various Cancers <i>In Vitro</i>Damla Uludağ, Nihal Karakaş
Cells|February 15, 2022
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering PerspectivesNihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, et al.
Frontiers in Pharmacology|June 9, 2022
Potential of Novel <i>Methyl Jasmonate</i> Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma CellsDamla Uludağ, Sadık Bay, Bilgesu Onur Sucu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Anticancer Research|July 7, 2021
IL13 Fused <i>Pseudomonas</i> Exotoxin Targets Various Cancers <i>In Vitro</i>Damla Uludağ, Nihal Karakaş
Cells|February 15, 2022
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering PerspectivesNihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, et al.
Frontiers in Pharmacology|June 9, 2022
Potential of Novel <i>Methyl Jasmonate</i> Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma CellsDamla Uludağ, Sadık Bay, Bilgesu Onur Sucu, et al.
Pageof 1